Literature DB >> 23588320

Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver.

X Chu1, K Korzekwa, R Elsby, K Fenner, A Galetin, Y Lai, P Matsson, A Moss, S Nagar, G R Rosania, J P F Bai, J W Polli, Y Sugiyama, K L R Brouwer.   

Abstract

Intracellular concentrations of drugs and metabolites are often important determinants of efficacy, toxicity, and drug interactions. Hepatic drug distribution can be affected by many factors, including physicochemical properties, uptake/efflux transporters, protein binding, organelle sequestration, and metabolism. This white paper highlights determinants of hepatocyte drug/metabolite concentrations and provides an update on model systems, methods, and modeling/simulation approaches used to quantitatively assess hepatocellular concentrations of molecules. The critical scientific gaps and future research directions in this field are discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23588320      PMCID: PMC3898878          DOI: 10.1038/clpt.2013.78

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  73 in total

1.  Identification of the rate-determining process in the hepatic clearance of atorvastatin in a clinical cassette microdosing study.

Authors:  K Maeda; Y Ikeda; T Fujita; K Yoshida; Y Azuma; Y Haruyama; N Yamane; Y Kumagai; Y Sugiyama
Journal:  Clin Pharmacol Ther       Date:  2011-08-10       Impact factor: 6.875

2.  Kinetic considerations for the quantitative assessment of efflux activity and inhibition: implications for understanding and predicting the effects of efflux inhibition.

Authors:  J Cory Kalvass; Gary M Pollack
Journal:  Pharm Res       Date:  2006-12-27       Impact factor: 4.200

3.  ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin.

Authors:  J E Keskitalo; O Zolk; M F Fromm; K J Kurkinen; P J Neuvonen; M Niemi
Journal:  Clin Pharmacol Ther       Date:  2009-05-27       Impact factor: 6.875

4.  Kinetic characterization of rat hepatic uptake of 16 actively transported drugs.

Authors:  Yoshiyuki Yabe; Aleksandra Galetin; J Brian Houston
Journal:  Drug Metab Dispos       Date:  2011-07-05       Impact factor: 3.922

5.  Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.

Authors:  J F Reinhard; E J Diliberto; O H Viveros; A J Daniels
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

6.  Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.

Authors:  Hannah M Jones; Hugh A Barton; Yurong Lai; Yi-An Bi; Emi Kimoto; Sarah Kempshall; Sonya C Tate; Ayman El-Kattan; J Brian Houston; Aleksandra Galetin; Katherine S Fenner
Journal:  Drug Metab Dispos       Date:  2012-02-16       Impact factor: 3.922

7.  PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me.

Authors:  Tadayuki Takashima; Satoshi Kitamura; Yasuhiro Wada; Masaaki Tanaka; Yoshihito Shigihara; Hideki Ishii; Ryosuke Ijuin; Susumu Shiomi; Takahiro Nakae; Yumiko Watanabe; Yilong Cui; Hisashi Doi; Masaaki Suzuki; Kazuya Maeda; Hiroyuki Kusuhara; Yuichi Sugiyama; Yasuyoshi Watanabe
Journal:  J Nucl Med       Date:  2012-04-12       Impact factor: 10.057

Review 8.  Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake.

Authors:  Mikko Niemi; Marja K Pasanen; Pertti J Neuvonen
Journal:  Pharmacol Rev       Date:  2011-01-18       Impact factor: 25.468

9.  Model analysis of the concentration-dependent permeability of P-gp substrates.

Authors:  Tatsuhiko Tachibana; Satoshi Kitamura; Motohiro Kato; Tetsuya Mitsui; Yoshiyuki Shirasaka; Shinji Yamashita; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2010-02-05       Impact factor: 4.200

10.  Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans.

Authors:  Takao Watanabe; Hiroyuki Kusuhara; Kazuya Maeda; Yoshihisa Shitara; Yuichi Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  2008-11-10       Impact factor: 4.030

View more
  80 in total

1.  Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques.

Authors:  Charles S Venuto; Marianthi Markatou; Yvonne Woolwine-Cunningham; Rosemary Furlage; Andrew J Ocque; Robin DiFrancesco; Emily O Dumas; Paul K Wallace; Gene D Morse; Andrew H Talal
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 2.  Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.

Authors:  Jennifer E Sager; Jingjing Yu; Isabelle Ragueneau-Majlessi; Nina Isoherranen
Journal:  Drug Metab Dispos       Date:  2015-08-21       Impact factor: 3.922

3.  Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis.

Authors:  B C Ferslew; C K Johnston; E Tsakalozou; A S Bridges; M F Paine; W Jia; P W Stewart; A S Barritt; K L R Brouwer
Journal:  Clin Pharmacol Ther       Date:  2015-03-15       Impact factor: 6.875

Review 4.  Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment.

Authors:  Andrew H Talal; Charles S Venuto; Islam Younis
Journal:  Clin Pharmacol Drug Dev       Date:  2017-03

5.  Intrahepatic Sampling for the Elucidation of Antiviral Clinical Pharmacology.

Authors:  Charles S Venuto; Andrew H Talal
Journal:  Clin Pharmacol Drug Dev       Date:  2017-03

6.  Determination of intracellular unbound concentrations and subcellular localization of drugs in rat sandwich-cultured hepatocytes compared with liver tissue.

Authors:  Nathan D Pfeifer; Kevin B Harris; Grace Zhixia Yan; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2013-08-29       Impact factor: 3.922

7.  Compartmental models for apical efflux by P-glycoprotein--part 1: evaluation of model complexity.

Authors:  Swati Nagar; Jalia Tucker; Erica A Weiskircher; Siddhartha Bhoopathy; Ismael J Hidalgo; Ken Korzekwa
Journal:  Pharm Res       Date:  2013-09-10       Impact factor: 4.200

8.  Exploring the structure-activity relationships of ABCC2 modulators using a screening approach.

Authors:  Gloria Wissel; Pavel Kudryavtsev; Leo Ghemtio; Päivi Tammela; Peter Wipf; Marjo Yliperttula; Moshe Finel; Arto Urtti; Heidi Kidron; Henri Xhaard
Journal:  Bioorg Med Chem       Date:  2015-04-17       Impact factor: 3.641

9.  Measurement of kinetic parameters for biotransformation of polycyclic aromatic hydrocarbons by trout liver S9 fractions: Implications for bioaccumulation assessment.

Authors:  John W Nichols; Melanie A Ladd; Patrick N Fitzsimmons
Journal:  Appl In Vitro Toxicol       Date:  2018

Review 10.  Computational approaches to analyse and predict small molecule transport and distribution at cellular and subcellular levels.

Authors:  Kyoung Ah Min; Xinyuan Zhang; Jing-yu Yu; Gus R Rosania
Journal:  Biopharm Drug Dispos       Date:  2013-12-10       Impact factor: 1.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.